Floatz logo

Clopidogrel

Mitral Valve Insufficiency

Chinese Academy of Medical Sciences, Fuwai HospitalSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Mitral Valve Insufficiency cohort.

Asset / SponsorPhaseRating
Aspirin
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase 4BB
Rivaroxaban
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase 4BB

Same molecule, other indications

Clopidogrel is also rated in:

myocardial infarctionActive
A
Indicative · Phase 4
81 / 100
View asset →
transient ischemic attackActive
BBB
Indicative · Phase 4
77 / 100
View asset →
peripheral arterial diseaseActive
BBB
Indicative · Phase 4
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →